Nurses' perception of solutions proposed by nurse leaders in face of COVID-19 pandemic: A cross-sectional study.

AIM: To evaluate the perception of bedside nurses regarding the implementation of solutions proposed by nurse leaders for patient and employee care during the COVID-19 pandemic. BACKGROUND: Nurse leaders have proposed solutions to better manage the challenges of the pandemic. However, multiple factors influence the transposal of actions from the tactical to the operational levels. METHOD: This cross-sectional study was carried out in a 620-bed non-profit institution. Participants were bedside nurses who completed an online survey. RESULTS: One hundred sixty-eight nurses participated in the study. Most of the proposed solutions were very effective and easily identified by the nurses. These solutions included adaptations of the physical structure, availability of medical supplies and adequacy of institutional protocols. The actions that stood out with low perception were adequate integration of new employees and the availability of remote work, hotel accommodations for frontline health care workers and day care for children whose parents worked at the hospital. CONCLUSION: Bedside nurses were able to recognize most of the solutions proposed by their nurse leaders during the COVID-19 pandemic. IMPLICATIONS FOR NURSING MANAGEMENT: Tactical-level nurse leaders need constant proximity to bedside nurses and continuous elucidation of the objectives to be achieved by the strategies adopted.

Performance of a multidisciplinary team and the impact of bundles for reducing health care associated infections in adult intensive care unit: 22 years of experience.

A retrospective cohort study was conducted to evaluate the bundle of techniques developed by the multidisciplinary team to minimize infections in an adult intensive care unit over a 22-year span. Two periods were analyzed: 1996-2006 and 2007-2017. Bloodstream infections, urinary tract infections, and ventilator-associated pneumonia declined 58.6%, 56.7%, and 82.6%, respectively (P < .05) from 2007 to 2017 compared with these same infections during 1996-2006.

Clinical characteristics and outcomes of COVID-19 patients admitted to the intensive care unit during the first year of the pandemic in Brazil: a single center retrospective cohort study.

OBJECTIVE: To describe clinical characteristics, resource use, outcomes, and to identify predictors of in-hospital mortality of patients with COVID-19 admitted to the intensive care unit. METHODS: Retrospective single-center cohort study conducted at a private hospital in São Paulo (SP), Brazil. All consecutive adult (≥18 years) patients admitted to the intensive care unit, between March 4, 2020 and February 28, 2021 were included in this study. Patients were categorized between survivors and non-survivors according to hospital discharge. RESULTS: During the study period, 1,296 patients [median (interquartile range) age: 66 (53-77) years] with COVID-19 were admitted to the intensive care unit. Out of those, 170 (13.6%) died at hospital (non-survivors) and 1,078 (86.4%) were discharged (survivors). Compared to survivors, non-survivors were older [80 (70-88) versus 63 (50-74) years; p<0.001], had a higher Simplified Acute Physiology Score 3 [59 (54-66) versus 47 (42-53) points; p<0.001], and presented comorbidities more frequently. During the intensive care unit stay, 56.6% of patients received noninvasive ventilation, 32.9% received mechanical ventilation, 31.3% used high flow nasal cannula, 11.7% received renal replacement therapy, and 1.5% used extracorporeal membrane oxygenation. Independent predictors of in-hospital mortality included age, Sequential Organ Failure Assessment score, Charlson Comorbidity Index, need for mechanical ventilation, high flow nasal cannula, renal replacement therapy, and extracorporeal membrane oxygenation support. CONCLUSION: Patients with severe COVID-19 admitted to the intensive care unit exhibited a considerable morbidity and mortality, demanding substantial organ support, and prolonged intensive care unit and hospital stay.

Epidemiologic and clinical features of patients with COVID-19 in Brazil

ABSTRACT Objective This study describes epidemiological and clinical features of patients with confirmed infection by SARS-CoV-2 diagnosed and treated at Hospital Israelita Albert Einstein , which admitted the first patients with this condition in Brazil. Methods In this retrospective, single-center study, we included all laboratory confirmed COVID-19 cases at Hospital Israelita Albert Einstein , São Paulo, Brazil, from February until March 2020. Demographic, clinical, laboratory and radiological data were analyzed. Results A total of 510 patients with a confirmed diagnosis of COVID-19 were included in this study. Most patients were male (56.9%) with a mean age of 40 years. A history of a close contact with a positive/suspected case was reported by 61.1% of patients and 34.4% had a history of recent international travel. The most common symptoms upon presentation were fever (67.5%), nasal congestion (42.4%), cough (41.6%) and myalgia/arthralgia (36.3%). Chest computed tomography was performed in 78 (15.3%) patients, and 93.6% of those showed abnormal results. Hospitalization was required for 72 (14%) patients and 20 (27.8%) were admitted to the Intensive Care Unit. Regarding clinical treatment, the most often used medicines were intravenous antibiotics (84.7%), chloroquine (45.8%) and oseltamivir (31.9%). Invasive mechanical ventilation was required by 65% of Intensive Care Unit patients. The mean length of stay was 9 days for all patients (22 and 7 days for patients requiring or not intensive care, respectively). Only one patient (1.38%) died during follow-up. Conclusion These results may be relevant for Brazil and other countries with similar characteristics, which are starting to deal with this pandemic. RESUMO Objetivo Descrever as características epidemiológicas e clínicas de pacientes com infecção confirmada pelo SARS-CoV-2, diagnosticados e tratados no Hospital Israelita Albert Einstein, que admitiu os primeiros pacientes com essa condição no Brasil. Métodos Neste estudo retrospectivo, de centro único, incluímos todos os casos com confirmação laboratorial de COVID-19 no Hospital Israelita Albert Einstein, em São Paulo (SP) de fevereiro a março de 2020. Foram analisados dados demográficos, clínicos, laboratoriais e radiológicos. Resultados Foram incluídos 510 pacientes com diagnóstico confirmado de COVID-19. A maioria dos pacientes era do sexo masculino (56,9%), com média de idade de 40 anos. Foi relatada história de contato próximo com um caso positivo/suspeito por 61,1% dos pacientes, e 34,4% tinham história de viagens internacionais recentes. Os sintomas mais comuns foram febre (67,5%), congestão nasal (42,4%), tosse (41,6%) e mialgia/artralgia (36,3%). A tomografia computadorizada de tórax foi realizada em 78 (15,3%) pacientes, e 93,6% deles apresentaram resultados anormais. A hospitalização foi necessária para 72 (14%) pacientes, e 20 (27,8%) foram admitidos na Unidade de Terapia Intensiva. Quanto ao tratamento clínico, os medicamentos mais utilizados foram antibióticos intravenosos (84,7%), cloroquina (45,8%) e oseltamivir (31,9%). A ventilação mecânica invasiva foi necessária em 65% dos pacientes na Unidade de Terapia Intensiva. O tempo médio de internação foi 9 dias para todos os pacientes (22 e 7 dias para pacientes que necessitaram ou não de cuidados intensivos, respectivamente). Apenas um (1,38%) paciente morreu durante o acompanhamento. Conclusão Estes resultados podem ser relevantes para o Brasil e outros países com características semelhantes, que começaram a lidar com essa pandemia.

Ações técnicas e gerenciais da enfermagem no Hospital Israelita Albert Einstein para atender na pandemia do COVID-19

Objetivo: relatar a experiência de liderar a implantação de ações técnicas e assistenciais em hospital para atendimento da pandemia do COVID-19. Método: Relato de Experiência da atuação como gestora na implantação das ações no Hospital Israelita Albert Einstein para atendimento à pandemia do novo coronavírus. Resultados: Foi criado um Comitê de Gestão de Crise multiprofissional que estabeleceu ações como a formação de um Núcleo de Inteligência e um de Epidemiologia, bem como para padronização das boas práticas e uso dos recursos. Conclusão: A participação neste momento de pandemia na experiência de protagonizar ações visando o melhor atendimento foi importante, reafirmando o papel da Enfermagem e do Enfermeiro na gestão na área hospitalar. (AU) Objective: to report the experience of leading the implementation of technical and assistance actions in a hospital to care for the pandemic of COVID-19. Method: Experience report of performance as a manager in the implementation of actions at Hospital Israelita Albert Einstein to attend the pandemic of the new coronavirus. Results: A multiprofessional Crisis Management Committee was created, which established actions such as the formation of an Intelligence Center and an Epidemiology Center, as well as for the standardization of good practices and the use of resources. Conclusion: Participation in this pandemic moment in the experience of leading actions aimed at better care was important, reaffirming the role of Nursing and Nurse in the management in the hospital area. (AU) Objetivo: informar la experiencia de liderar la implementación de acciones técnicas y de asistencia en un hospital para atender la pandemia de COVID-19. Método: Informe de experiencia del desempeño como gerente en la implementación de acciones en el Hospital Israelita Albert Einstein para asistir a la pandemia del nuevo coronavirus. Resultados: se creó un Comité de Gestión de Crisis multiprofesional, que estableció acciones como la formación de un Centro de Inteligencia y un Centro de Epidemiología, así como para la estandarización de buenas prácticas y el uso de recursos. Conclusión: La participación en este momento pandémico en la experiencia de liderar acciones dirigidas a una mejor atención fue importante, reafirmando el papel de Enfermería y Enfermera en la gestión en el área hospitalaria. (AU)

Epidemiologic and clinical features of patients with COVID-19 in Brazil.

Objective This study describes epidemiological and clinical features of patients with confirmed infection by SARS-CoV-2 diagnosed and treated at Hospital Israelita Albert Einstein , which admitted the first patients with this condition in Brazil. Methods In this retrospective, single-center study, we included all laboratory confirmed COVID-19 cases at Hospital Israelita Albert Einstein , São Paulo, Brazil, from February until March 2020. Demographic, clinical, laboratory and radiological data were analyzed. Results A total of 510 patients with a confirmed diagnosis of COVID-19 were included in this study. Most patients were male (56.9%) with a mean age of 40 years. A history of a close contact with a positive/suspected case was reported by 61.1% of patients and 34.4% had a history of recent international travel. The most common symptoms upon presentation were fever (67.5%), nasal congestion (42.4%), cough (41.6%) and myalgia/arthralgia (36.3%). Chest computed tomography was performed in 78 (15.3%) patients, and 93.6% of those showed abnormal results. Hospitalization was required for 72 (14%) patients and 20 (27.8%) were admitted to the Intensive Care Unit. Regarding clinical treatment, the most often used medicines were intravenous antibiotics (84.7%), chloroquine (45.8%) and oseltamivir (31.9%). Invasive mechanical ventilation was required by 65% of Intensive Care Unit patients. The mean length of stay was 9 days for all patients (22 and 7 days for patients requiring or not intensive care, respectively). Only one patient (1.38%) died during follow-up. Conclusion These results may be relevant for Brazil and other countries with similar characteristics, which are starting to deal with this pandemic.